{"title":"Platinum catalyst-functionalized cylindrical graft copolymer micelles for dual catalytic and cytotoxic activity†","authors":"Kyosuke Seryu, Chieri Inada and Tomoki Nishimura","doi":"10.1039/D5MA00518C","DOIUrl":null,"url":null,"abstract":"<p >Catalytic prodrug activation offers a promising approach to cancer therapy, but integrating catalytic and therapeutic functions within a single platform remains challenging. In addition, low-molecular weight metal catalysts suffer from rapid clearance and limited <em>in vivo</em> efficacy. Here, we present a platinum complex-conjugated polymeric micellar system, constructed from amphiphilic poly(acrylic acid)-<em>graft</em>-poly(propylene oxide), which self-assembles into short cylindrical micelles (<em>ca.</em> 50 nm in length) in aqueous solution. The micelles are functionalized with a cisplatin-derived Pt(<small>IV</small>) metal complex, which is released under reductive conditions and converted into catalytically active Pt(<small>II</small>) species capable of deprotecting an <em>N</em>-propargylated 5-fluorouracil prodrug. The catalytic transformation proceeds more efficiently under mildly acidic conditions (pH = 6.0), achieving up to 35% conversion after 96 hours. Cell viability assays using CT26 cancer cells showed a decrease in viability from 60% (Pt-micelle alone) to below 50% when combined with the prodrug, indicating dual catalytic and cytotoxic activity <em>in vitro</em>. These findings provide a proof-of-concept for a dual-functional nanocarrier system capable of localized prodrug activation and therapeutic action, offering a promising strategy for advancing metal-catalyzed cancer therapy.</p>","PeriodicalId":18242,"journal":{"name":"Materials Advances","volume":" 17","pages":" 6001-6007"},"PeriodicalIF":4.7000,"publicationDate":"2025-07-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://pubs.rsc.org/en/content/articlepdf/2025/ma/d5ma00518c?page=search","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Materials Advances","FirstCategoryId":"1085","ListUrlMain":"https://pubs.rsc.org/en/content/articlelanding/2025/ma/d5ma00518c","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MATERIALS SCIENCE, MULTIDISCIPLINARY","Score":null,"Total":0}
引用次数: 0
Abstract
Catalytic prodrug activation offers a promising approach to cancer therapy, but integrating catalytic and therapeutic functions within a single platform remains challenging. In addition, low-molecular weight metal catalysts suffer from rapid clearance and limited in vivo efficacy. Here, we present a platinum complex-conjugated polymeric micellar system, constructed from amphiphilic poly(acrylic acid)-graft-poly(propylene oxide), which self-assembles into short cylindrical micelles (ca. 50 nm in length) in aqueous solution. The micelles are functionalized with a cisplatin-derived Pt(IV) metal complex, which is released under reductive conditions and converted into catalytically active Pt(II) species capable of deprotecting an N-propargylated 5-fluorouracil prodrug. The catalytic transformation proceeds more efficiently under mildly acidic conditions (pH = 6.0), achieving up to 35% conversion after 96 hours. Cell viability assays using CT26 cancer cells showed a decrease in viability from 60% (Pt-micelle alone) to below 50% when combined with the prodrug, indicating dual catalytic and cytotoxic activity in vitro. These findings provide a proof-of-concept for a dual-functional nanocarrier system capable of localized prodrug activation and therapeutic action, offering a promising strategy for advancing metal-catalyzed cancer therapy.